American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Preaddiction—A Missing Concept for Treating Substance Use Disorders

Lead Story: Preaddiction—A Missing Concept for Treating Substance Use Disorders

Tuesday 19th July 2022

Learn about 'preaddiction' and its potential to prevent severe substance use disorders in this episode of 'This Week in Addiction Medicine'.
8 minutes
Informative
Educational
Thought-provoking
Engaging
Motivational

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Preaddiction: A New Approach to Early Intervention in Substance Use Disorders

Engaging the public in screening and intervening with prediabetes has succeeded in halting progression for sud.
Imagine if we could identify and address substance use issues before they escalate. That's the intriguing idea behind 'preaddiction', a concept discussed in this episode of 'This Week in Addiction Medicine'. Drawing parallels to the successful early intervention strategies used for prediabetes, the hosts explore how similar methods could be applied to mild to moderate substance use disorders (SUD).
They discuss an opinion piece from JAMA Psychiatry that advocates for early screening and intervention to prevent the progression to severe SUD. Existing tools like brief interventions and computerized cognitive behavioral therapy are highlighted as potential game-changers. But it's not just about tools; the conversation also touches on the need for education in medical and nursing schools and proper reimbursement for these services. The hosts provide a well-rounded discussion, making it clear that a multifaceted approach is essential.
This episode doesn't stop at preaddiction. It also delves into various pressing topics in addiction medicine, including the relationship between cannabis use disorder and mental health issues like depression and anxiety, and innovative interventions for methamphetamine psychosis in emergency settings. The availability of critical medications like buprenorphine and naloxone in community pharmacies is another key point, along with the impact of hepatitis C treatment on those who inject drugs.
Ethical and legal considerations surrounding the use of psychedelics in brain wellness spas are also explored, as well as access to buprenorphine for physicians under state monitoring programs. Finally, the episode highlights a global shift towards a public health approach to substance use disorders. With expert commentary and engaging discussions, this episode offers valuable insights for anyone interested in the evolving field of addiction medicine.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.